Broad-spectrum forensic toxicological screening for 400+ substances by LC-MS/MS from whole blood or urine.
400+ substances
3–5 working days
This comprehensive screening method detects over 400 psychoactive substances, providing the broadest available forensic toxicological coverage for unknown substance identification.
Clinical indications include:
400+ substances including classical drugs of abuse, designer drugs and novel psychoactive substances (NPS), psychotropic medications, barbiturates, synthetic cannabinoids, synthetic cathinones, and novel synthetic opioids.
Broad-spectrum screening by high-resolution LC-MS/MS with library matching against a continuously updated database of 400+ substances. Includes novel psychoactive substances and designer drugs not covered by conventional targeted panels.
From enquiry to results — a straightforward process.
This test is available to healthcare professionals, wellness brands, clinics, and research institutions worldwide. We currently serve partners in:
Whether you need testing services for your patients, white-label kits for your brand, or method transfer to your own laboratory — get in touch to discuss how we can work together.
This screen provides broad-spectrum detection of over 400 substances from whole blood or urine by LC-MS/MS. Coverage includes prescription drugs, illicit substances, novel psychoactive substances (NPS), synthetic cannabinoids, synthetic cathinones, designer benzodiazepines, novel opioids, and toxins.
A comprehensive screen is indicated in cases involving unknown substance exposure, suspected poisoning, post-mortem toxicology where the cause of death is unclear, clinical emergencies with altered consciousness, or when a targeted panel may miss an unexpected or novel compound.
Whole blood or urine is collected following forensic chain-of-custody protocols. Proper sample identification, sealing, and documentation are essential to ensure results are admissible in legal proceedings and forensic investigations.
Results are typically delivered within 3 to 5 working days from the time your sample arrives at our laboratory. The analysis is performed by LC-MS/MS with validated screening methodology for forensic applications.
Yes, any substances detected during the screening phase can be followed up with targeted quantitative analysis. This two-step approach — qualitative screening followed by quantitative confirmation — provides the analytical rigour required for forensic reporting and clinical decision-making.
Masdiag's comprehensive forensic screen is available to forensic laboratories, law enforcement agencies, and healthcare professionals in Europe, the United Kingdom, Asia, Australia, New Zealand, and the United States. Contact us to discuss testing services or method transfer.
Whether you need testing services, method transfer, or white-label kit development — we'd love to hear from you.